Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________ FORM 10-K __________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Registrant as Specif ...

10x Genomics, Inc. (NASDAQ:TXG) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer & Co-Founder Justin McAnear - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Dan Arias - Stifel Patrick Donnelly - Citi Kyle Mikson - Canaccord Genuity Dan Brennan - Cowen Julia Qin - JPMorgan Michael Ryskin - Bank of America Matt Sykes - Goldman Sachs Operato ...

Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 45-5614458 (State or other jurisdiction of incorporation or organization) (Mark One) ☒ QUARTERLY REPOR ...

10x Genomics, Inc. (NASDAQ:TXG) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov - Chief Executive Officer & Co-founder Jim Wilbur - Chief Commercial Officer Justin McAnear - Chief Financial Officer Conference Call Participants Matt Sykes - Goldman Sachs Michael Ryskin - Bank of America Daniel Arias - Stifel Tejas Savant - Morgan Stanley Patrick Donnelly - Citi Daniel Brennan - Cowen Julia Qin - JP Morgan ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 10x Genomics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 45-5614458 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 6230 Stoneridge Mall Road Pleasanton, California 94588 (Address of princi ...

10x Genomics, Inc. (NASDAQ:TXG) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov - Chief Executive Officer & Co-founder Justin McAnear - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Dan Brennan - Cohen Mike Ryskin - Bank of America Julia Qin - JPMorgan Patrick Donnelly - Citi Matt Larew - William Blair Matt Sykes - Goldman Sachs Operator Hello and welcome to the 10x Genom ...

For the quarterly period ended March 31, 2022 OR Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of R ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________ FORM 10-K __________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Registrant as Specif ...

10x Genomics, Inc. (NASDAQ:TXG) Q4 2021 Earnings Conference Call February 16, 2022 4:30 PM ET Company Participants Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co-Founder Justin McAnear - CFO Conference Call Participants Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Dan Brennan - Cowen Tejas Savant - Morgan Stanley Patrick Donnelly - Citi Dan Arias - Stifel Matt Larew - William Blair Matt Sykes - Goldman Sachs Operator Hello, good afternoon, and welcome to the 10x ...

Mastering Biology to Advance Human Health Serge Saxonov, CEO and Co-founder GENOMICS © 10X GENOMICS, INC. 2022. 1 Disclaimer Certain statements in this presentation and the accompanying oral commentary are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements, other than statements of historical facts may be f ...